Compare RMTI & MLCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RMTI | MLCI |
|---|---|---|
| Founded | 1994 | N/A |
| Country | United States | United States |
| Employees | 300 | 21 |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.7M | 31.3M |
| IPO Year | 2022 | N/A |
| Metric | RMTI | MLCI |
|---|---|---|
| Price | $0.66 | $2.84 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.00 | N/A |
| AVG Volume (30 Days) | ★ 316.2K | 26.0K |
| Earning Date | 05-07-2026 | 05-08-2026 |
| Dividend Yield | N/A | ★ 2.63% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $69,258,000.00 | N/A |
| Revenue This Year | $8.64 | N/A |
| Revenue Next Year | $8.44 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.60 | $2.68 |
| 52 Week High | $2.10 | $8.68 |
| Indicator | RMTI | MLCI |
|---|---|---|
| Relative Strength Index (RSI) | 35.53 | 33.45 |
| Support Level | $0.60 | $2.68 |
| Resistance Level | $1.00 | $3.13 |
| Average True Range (ATR) | 0.04 | 0.18 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 26.60 | 15.90 |
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, acid, and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate, among others. The company delivers the majority of its hemodialysis concentrates products and mixers to dialysis clinics throughout the United States and internationally, utilizing its own delivery trucks and third-party carriers.
Mount Logan Capital Inc operates as emerging asset management and investment firm focused on investing in public and private debt securities in the North American market. The company's reporting segments include asset management and insurance. The company through its subsidiaries, earns management and incentive fees and servicing fees for providing investment management, monitoring and other services to investment vehicles and advisers. The Asset Management segment comprises all fee generating activities. The Insurance Solutions segment, which derives maximum revenue, consists of two product lines within the insurance business, LTC and MYGA.